Epidemiology and risk factors of self-reported systemic allergic reactions to a Hymenoptera venom in beekeepers worldwide: a protocol for a systematic review of observational studies.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
05 07 2022
Historique:
entrez: 5 7 2022
pubmed: 6 7 2022
medline: 7 7 2022
Statut: epublish

Résumé

Systemic allergic reaction (SAR) to a Hymenoptera venom is a potentially life-threatening disorder. The rate of SAR between beekeepers in comparison with a healthy individual is different. The risk for an SAR is particularly high in beekeepers due to their persistent or seasonal exposure to the stinging Hymenoptera. We aim to provide a critical appraisal and a synthesis of evidence-based data from epidemiological observational studies, focusing on SARs to a Hymenoptera venom and the associated risk factors for SARs in beekeepers worldwide. Searching will include seven electronic databases for published studies without language restrictions, from inception up to 3 August 2021, and it will be rerun for all electronic databases prior publication. Only epidemiological observational studies in beekeepers will be included. The risk of bias in the included studies will be appraised by using the Joanna Briggs Institute Critical Appraisal Checklist for Analytical Cross-Sectional Studies and the Newcastle-Ottawa Scale, adapted for cross-sectional studies. For the certainty of evidence, the Grading of Recommendations Assessment, Development and Evaluation approach will be used. Qualitative synthesis will be presented in a tabulated format with the selected characteristics across primary studies and the main outcome of interest. A meta-analysis is planned to be performed if there will be a sufficient number of homogeneous studies with complete data. The Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols 2015 statement will guide the reporting of this systematic literature review. No ethics approval is needed to conduct the systematic literature review since it will be solely based on the published literature. Findings will be disseminated through the relevant conferences, peer-review and open-access journals.

Identifiants

pubmed: 35790330
pii: bmjopen-2021-058130
doi: 10.1136/bmjopen-2021-058130
pmc: PMC9258514
doi:

Substances chimiques

Arthropod Venoms 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e058130

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Clin Exp Allergy. 2009 Oct;39(10):1467-76
pubmed: 19622088
Curr Opin Allergy Clin Immunol. 2002 Aug;2(4):341-6
pubmed: 12130949
J Allergy Clin Immunol. 1984 Mar;73(3):332-40
pubmed: 6699314
Chem Immunol Allergy. 2010;95:141-156
pubmed: 20519887
Curr Opin Allergy Clin Immunol. 2005 Aug;5(4):343-7
pubmed: 15985817
Front Immunol. 2020 Oct 22;11:579409
pubmed: 33193378
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Eur Ann Allergy Clin Immunol. 2019 Nov;51(6):244-258
pubmed: 31594296
BMC Public Health. 2013 Feb 19;13:154
pubmed: 23421987
Sci Data. 2016 Nov 08;3:160097
pubmed: 27824336

Auteurs

Tanja Carli (T)

National Institute of Public Health of the Republic of Slovenia, Ljubljana, Slovenia.
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia.

Igor Locatelli (I)

University of Ljubljana, Faculty of Pharmacy, Department of Social Pharmacy, Ljubljana, Slovenia.

Mitja Košnik (M)

University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
University of Ljubljana, Faculty of Medicine, Chair of Internal Medicine, Ljubljana, Slovenia.

Andreja Kukec (A)

National Institute of Public Health of the Republic of Slovenia, Ljubljana, Slovenia andreja.kukec@mf.uni-lj.si.
University of Ljubljana, Faculty of Medicine, Chair of Public Health, Ljubljana, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH